Therapeutic Effects of Short-Term Monochromatic Infrared Energy Therapy on Patients With Knee Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Study

被引:15
|
作者
Hsieh, Ru-Lan [1 ,2 ]
Lo, Min-Tzu [3 ]
Lee, Wen-Chung [4 ]
Liao, Wei-Cheng [2 ]
机构
[1] Shin Kong Wu Ho Su Mem Hosp, Dept Phys Med & Rehabil, Taipei 11101, Taiwan
[2] Taipei Med Univ, Taipei, Taiwan
[3] Natl Taiwan Univ, Inst Epidemiol & Preventat Med, Taipei 10764, Taiwan
[4] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan
来源
关键词
International Classification of Functioning; Disability and Health; knee osteoarthritis; monochromatic infrared energy; therapeutic effect; DIABETIC PERIPHERAL NEUROPATHY; OUTCOME SCORE KOOS; HOSPITAL ANXIETY; LIGHT THERAPY; PAIN; VALIDATION; SENSATION; CLASSIFICATION; RELIABILITY; INSTRUMENT;
D O I
10.2519/jospt.2012.3881
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
STUDY DESIGN: Randomized, double-blind, placebo-controlled study. OBJECTIVES: To examine the short-term therapeutic effects of monochromatic infrared energy (MIRE) on participants with knee osteoarthritis (OA). Patients were assessed according to the International Classification of Functioning, Disability and Health. BACKGROUND: MIRE is commonly used in therapy for patients with peripheral neuropathies. However, research has not focused intensively on the therapeutic effects of MIRE in patients with knee OA. METHODS: This study enrolled 73 participants with knee OA. Participants received six 40-minute sessions of active or placebo MIRE treatment (890-nm wavelength; power, 6.24 W; energy density, 2.08 J/cm(2)/min; total energy, 83.2 J/cm(2)) over the knee joints for 2 weeks. International Classification of Functioning, Disability and Health related outcomes were collected weekly over 4 weeks using the Knee injury and Osteoarthritis Outcome Score, Lysholm Knee Scale, Hospital Anxiety and Depression Scale, Multidimensional Fatigue Inventory, Chronic Pain Grade questionnaire, World Health Organization Quality of Life-brief version, and OA Quality of Life Questionnaire. Data were analyzed by repeated-measures analysis of variance. RESULTS: No statistically significant differences were found for the interaction of group by time for Knee injury and Osteoarthritis Outcome Score scores, including pain, other symptoms, function in daily living, function in sport and recreation, and knee-related quality of life. Scores on the Lysholm Knee Scale, Hospital Anxiety and Depression Scale, Multidimensional Fatigue Inventory, Chronic Pain Grade questionnaire, World Health Organization Quality of Life-brief version, and OA Quality of Life Questionnaire also showed no significant differences between the 2 groups at any of the 4 follow-up assessments. CONCLUSION: Short-term MIRE therapy provided no beneficial effects to body functions, activities, participation, and quality of life in patients with knee OA. LEVEL OF EVIDENCE: Therapy, level 1b-.J Orthop Sports Phys Ther 2012;42(11):947-956, Epub 5 September 2012. doi:10.2519/jospt.2012.3881
引用
收藏
页码:947 / 956
页数:10
相关论文
共 50 条
  • [22] Naratriptan as short-term prophylaxis of menstrually associated migraine:: A randomized, double-blind, placebo-controlled study
    Newman, L
    Mannix, LK
    Landy, S
    Silberstein, S
    Lipton, RB
    Putnam, DGP
    Watson, C
    Jöbsis, M
    Batenhorst, A
    O'Quinn, S
    HEADACHE, 2001, 41 (03): : 248 - 256
  • [23] Short-term influence of Immufen™ on mild allergic rhinitis: a randomized, double-blind, placebo-controlled study
    Mamatha, K.
    Aryan, Manu Kanjoormana
    Prabhakaran, Prathibha
    Mulakal, Johannah Natinga
    Das, S. Syam
    Krishnakumar, Im
    Panicker, Sreejith Parameswara
    FRONTIERS IN ALLERGY, 2024, 5
  • [24] Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study
    Moller, I.
    Perez, M.
    Monfort, J.
    Benito, P.
    Cuevas, J.
    Perna, C.
    Domenech, G.
    Herrero, M.
    Montell, E.
    Verges, J.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 : S32 - S40
  • [25] A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee
    Hughes, R
    Carr, A
    RHEUMATOLOGY, 2002, 41 (03) : 279 - 284
  • [26] Efficacy and safety of diacerein and celecoxib combination therapy for knee osteoarthritis: A double-blind, randomized, placebo-controlled prospective study
    Youn, Sangah
    Choi, Ji Hye
    Kim, Chulmin
    Kim, Seon-Mee
    Choi, Whan Seok
    MEDICINE, 2023, 102 (39) : E35317
  • [27] Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled study
    Alberda, C
    Gramlich, L
    Field, C
    McCargar, L
    Meddings, J
    Madsen, K
    GASTROENTEROLOGY, 2005, 128 (04) : A281 - A282
  • [28] Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome
    Bliwise, DL
    Freeman, A
    Ingram, CD
    Rye, DB
    Chakravorty, S
    Watts, RL
    SLEEP MEDICINE, 2005, 6 (02) : 141 - 147
  • [29] Short-term testosterone augmentation in male schizophrenics - A randomized, double-blind, placebo-controlled trial
    Ko, Young-Hoon
    Lew, Young-Min
    Jung, Sung-Won
    Joe, Sook-Haeng
    Lee, Chang-Hyun
    Jung, Hyun-Gang
    Lee, Moon-Soo
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (04) : 375 - 383
  • [30] Zolpidem in the treatment of short-term insomnia: A randomized, double-blind, placebo-controlled clinical trial
    Dockhorn, RJ
    Dockhorn, DW
    CLINICAL NEUROPHARMACOLOGY, 1996, 19 (04) : 333 - 340